Neola Medical AB (publ)
Stockholm Stock ExchangeTotal Valuation
Neola Medical AB (publ) carries a market capitalization of 74.65M, placing it among publicly traded companies globally.
| Market Cap | 74.65M |
| Enterprise Value | N/A |
Share Statistics
Neola Medical AB (publ) currently has 80.70M shares outstanding.
| Shares Outstanding | 80.70M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.89 |
| P/TBV Ratio | 5.74 |
| P/FCF Ratio | -7.22 |
| P/OCF Ratio | -7.22 |
Financial Position
Neola Medical AB (publ) maintains a current ratio of 5.75, meaning it holds 5.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.75 |
| Quick Ratio | 5.38 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -14.46 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | -192.99 |
Stock Price Statistics
Neola Medical AB (publ)'s stock has declined approximately -60.47009% over the past 52 weeks. The 50-day moving average sits at 1.04, while the 200-day moving average is 1.16.
| Beta (5Y) | N/A |
| 52-Week Price Change | -60.47009% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.16 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -11.09M, while operating income came in at -11.09M.
| Revenue | N/A |
| Gross Profit | 8.01M |
| Operating Income | -11.09M |
| Pretax Income | -11.02M |
| Net Income | -11.02M |
| EBITDA | -11.09M |
| EBIT | -11.09M |
| Earnings Per Share (EPS) | -0.14 |
Balance Sheet
Total book value stands at -94.26M, with working capital of 14.24M providing operational flexibility.
| Cash & Cash Equivalents | 16.12M |
| Total Debt | N/A |
| Net Debt | -16.12M |
| Equity (Book Value) | -94.26M |
| Book Value Per Share | -1.19 |
| Working Capital | 14.24M |
Cash Flow
Neola Medical AB (publ) produced -11.60M in operating cash flow over the past twelve months.
| Operating Cash Flow | -11.60M |
| Capital Expenditures | N/A |
| Free Cash Flow | -11.60M |
| FCF Per Share | -0.15 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -21.33 |
| FCF Yield | -13.86 |
Stock Splits
Neola Medical AB (publ)'s most recent stock split took place on September 30, 2022 with a 98:99 split ratio.
| Last Split Date | 9/30/2022 |
| Split Ratio | 98:99 |
Scores
Neola Medical AB (publ) posts an Altman Z-Score of 7.70, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.70 |